Live from the NIH registry
Studies recruiting near Springfield right now
Top 25 of 325 recruiting studies, sorted by proximity — each links to its official registry page
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
Smilow Cancer Hospital at Saint Francis — Hartford, Connecticut (25.4 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
CLOZAPINE Response in Biotype-1
Schizophrenia, Schizoaffective Disorder
Phase 4
Interventional 524 participants sought
Hartford Healthcare — Hartford, Connecticut (25.4 mi)
· Sponsor: University of Texas Southwestern Medical Center
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Prostate Cancer
Phase 4
Interventional 700 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Novartis Pharmaceuticals
Utility of PCD Diagnostics to Improve Clinical Care
Primary Ciliary Dyskinesia
N/A
Observational 50 participants sought
Pulmonary Division — Hartford, Connecticut (25.4 mi)
· Sponsor: Connecticut Children's Medical Center
Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder
Problems Related to Social Environment
N/A
Interventional 318 participants sought
University of Connecticut — Storrs, Connecticut (25.9 mi)
· Sponsor: NYU Langone Health
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
The CONFORM Pivotal Trial
Atrial Fibrillation, Stroke
N/A
Interventional 1,600 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: Conformal Medical, Inc
Army-SPRING Army-Suicide Prevention Research
Suicide
Phase 1
Interventional 57 participants sought
Connecticut Army National Guard — Hartford, Connecticut (25.4 mi)
· Sponsor: University of Pennsylvania
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
Hartford HealthCare - Manchester — Manchester, Connecticut (23.5 mi)
· Sponsor: National Cancer Institute (NCI)
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Endometrial Cancer, Endometrioid Adenocarcinoma
N/A
Observational 1,715 participants sought
Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
Glycogen Storage Disease Type Ia
N/A
Observational 140 participants sought
University of Connecticut Health Center — Hartford, Connecticut (25.4 mi)
· Sponsor: Ultragenyx Pharmaceutical Inc
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 4,300 participants sought
Research Site — Hartford, Connecticut (25.4 mi)
· Sponsor: AstraZeneca
Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
Glioma
Phase 2
Interventional 57 participants sought
Hartford Healthcare Alliance (Data Collection Only) — Hartford, Connecticut (25.4 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: NRG Oncology
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: Children's Oncology Group
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 2
Interventional 80 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: Children's Oncology Group
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Type B Aortic Dissection
N/A
Interventional 1,100 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Duke University
Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity
Dyslipidemias, Obesity
EARLY/Phase 1
Interventional 130 participants sought
University of Connecticut — Storrs, Connecticut (25.9 mi)
· Sponsor: University of Connecticut
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Elixia SISU BHR - Springfield — Springfield, Massachusetts (2.8 mi)
· Sponsor: Sparrow Pharmaceuticals
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Integrative Training Program for Pediatric Sickle Cell Pain
Sickle Cell Disease
N/A
Interventional 155 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: Emory University
Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
Leukemia, Myelodysplastic Syndromes
N/A
Observational 300 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: Dana-Farber Cancer Institute
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Schizophrenia Spectrum and Other Psychotic Disorders, Schizophrenia
N/A
Observational 320 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Beth Israel Deaconess Medical Center